Promising new HIV-AIDS drug, 1st in new class, approved for Canadian market

Metronews: "TORONTO - Health Canada has granted licence approval for a new HIV-AIDS drug, the first in a promising new class of medications. Drug maker Merck Frosst says it has been given permission to bring Isentress to the Canadian market for treatment of HIV-positive people whose viruses are resistant to multiple other HIV drugs. "